54 related articles for article (PubMed ID: 1304463)
1. Prospective double-blind study of CEE3 in peri- and postmenopausal women: effects on bone loss and lipoprotein lipids.
Cheng GJ; Liu JL; Zhang Q; Ye HF; Wang ZQ; Pan HP
Chin Med J (Engl); 1992 Nov; 105(11):929-33. PubMed ID: 1304463
[TBL] [Abstract][Full Text] [Related]
2. [A prospective study of nylestriol on plasma lipids in postmenopausal women].
Cheng GJ
Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):349-51, 387-8. PubMed ID: 1804605
[TBL] [Abstract][Full Text] [Related]
3. Nylestriol replacement therapy in postmenopausal women. A three-year prospective study.
Cheng GJ; Liu JL; Zhang Q; Fan W; Ye HF; Wang ZQ; Pan HP
Chin Med J (Engl); 1993 Dec; 106(12):911-6. PubMed ID: 8198628
[TBL] [Abstract][Full Text] [Related]
4. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[TBL] [Abstract][Full Text] [Related]
5. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
Bunyavejchevin S; Limpaphayom KK
J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
[TBL] [Abstract][Full Text] [Related]
6. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
7. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
8. [The effects of progestin on the bone metabolism in postmenopausal women].
Ren Y; Zhu G
Zhonghua Fu Chan Ke Za Zhi; 1995 Mar; 30(3):135-7. PubMed ID: 7796643
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
[TBL] [Abstract][Full Text] [Related]
10. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
[TBL] [Abstract][Full Text] [Related]
11. [Effect of nylestriol on postmenopausal uterine endometrium].
Liu JL
Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):76-8, 122. PubMed ID: 8344085
[TBL] [Abstract][Full Text] [Related]
12. [Prospective study on nylestriol replacement therapy in postmenopausal women].
Cheng GJ
Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):534-8, 569. PubMed ID: 8313746
[TBL] [Abstract][Full Text] [Related]
13. [Postmenopausal women: changes in plasma lipids with different estrogen replacement therapies].
Blumel JE; Brandt A; Garabagno A; Cubillos M; Lozano A
Rev Med Chil; 1990 Apr; 118(4):382-7. PubMed ID: 2133147
[TBL] [Abstract][Full Text] [Related]
14. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
Ho SC; Chen YM; Ho SS; Woo JL
Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A double-blind, prospective study of sequential versus continuous therapy.
Luciano AA; De Souza MJ; Roy MP; Schoenfeld MJ; Nulsen JC; Halvorson CV
J Reprod Med; 1993 Mar; 38(3):207-14. PubMed ID: 8487239
[TBL] [Abstract][Full Text] [Related]
17. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
[TBL] [Abstract][Full Text] [Related]
18. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
Barnes RB; Roy S; Lobo RA
Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial.
Meschia M; Bruschi F; Soma M; Amicarelli F; Paoletti R; Crosignani P
Menopause; 1998; 5(3):157-62. PubMed ID: 9774761
[TBL] [Abstract][Full Text] [Related]
20. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
